ConductScience.org, home

Paper42564652

Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.

Kwon JY and 10 others. Case Rep Urol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA. Papers, record 42564652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42564652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.
PubMed
Journal
Case Rep Urol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-26
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18199991Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases.Cancer1994https://conductscience.org/library/papers/8199991PubMed
226903579Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.J Clin Oncol2016https://conductscience.org/library/papers/26903579PubMed
322140652Characterization of KRAS rearrangements in metastatic prostate cancer.Cancer Discov2011https://conductscience.org/library/papers/22140652PubMed
430467381Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.Oncogene2019https://conductscience.org/library/papers/30467381PubMed
519467692Pleomorphic giant cell carcinoma of the urinary bladder.Hum Pathol2009https://conductscience.org/library/papers/19467692PubMed
635641216Rational Second-Generation Antiandrogen Use in Prostate Cancer.Oncologist2022https://conductscience.org/library/papers/35641216PubMed
729944471Prostatic Adenocarcinoma With Focal Pleomorphic Giant Cell Features: A Series of 30 Cases.Am J Surg Pathol2018https://conductscience.org/library/papers/29944471PubMed
815859643Pleomorphic giant cell carcinoma of the prostate.Arch Pathol Lab Med2005https://conductscience.org/library/papers/15859643PubMed
939293462
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial.
Lancet2024https://conductscience.org/library/papers/39293462PubMed
1036297404[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36297404PubMed
1136259290Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience.Prostate2023https://conductscience.org/library/papers/36259290PubMed
1228527407Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer.Cancer Treat Rev2017https://conductscience.org/library/papers/28527407PubMed
138417812Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.Cancer Res1993https://conductscience.org/library/papers/8417812PubMed
142449118Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.Anticancer Res1987https://conductscience.org/library/papers/2449118PubMed
1528059767Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.Science2017https://conductscience.org/library/papers/28059767PubMed
1642564652Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.Case Rep Urol2026https://conductscience.org/library/papers/42564652PubMed
1737604763
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study.
Eur Urol Oncol2024https://conductscience.org/library/papers/37604763PubMed
1834161051Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.N Engl J Med2021https://conductscience.org/library/papers/34161051PubMed
1931748536The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.Nat Commun2019https://conductscience.org/library/papers/31748536PubMed
2032030484Polypoidal giant cancer cells in metastatic castration-resistant prostate cancer: observations from the Michigan Legacy Tissue Program.Med Oncol2020https://conductscience.org/library/papers/32030484PubMed

See all 38 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42564652Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.Case Rep Urol2026https://conductscience.org/library/papers/42564652

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FOLH12346PubTator's text mininghttps://conductscience.org/library/genes/2346NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene
RB15925PubTator's text mininghttps://conductscience.org/library/genes/5925NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42564652

GET https://conductscience.org/api/papers/v1/42564652/references?page=2